Brian Shield, Boston Red Sox VP of IT, Joins Flurotech Advisory Board
February 04, 2021 08:00 ET
|
FluroTech Ltd.
CALGARY, Alberta, Feb. 04, 2021 (GLOBE NEWSWIRE) -- FluroTech Ltd. (TSXV: TEST) (OTCQB: FLURF) (“FluroTech” or the “Company”), a leading developer of spectroscopy-based technology, together with...
FluroTech Provides Executive Update on Program Advancements
February 03, 2021 08:00 ET
|
FluroTech Ltd.
CALGARY, Alberta, Feb. 03, 2021 (GLOBE NEWSWIRE) -- FluroTech Ltd. (TSXV: TEST) (OTCQB: FLURF) (“FluroTech” or the “Company”), a leading developer of spectroscopy-based technology, together with...
FluroTech Retains Market-Making Services
January 27, 2021 16:10 ET
|
FluroTech Ltd.
CALGARY, Alberta, Jan. 27, 2021 (GLOBE NEWSWIRE) -- FluroTech Ltd. (TSXV: TEST) (OTCQB: FLURF) (“FluroTech” or the “Company”), is pleased to announce that is has engaged Venture Liquidity Providers...
FluroTech Expands nanoComposix Mandate; Initiating Covid-19 Test Performance Evaluation and Validation
January 25, 2021 09:00 ET
|
FluroTech Ltd.
CALGARY, Alberta, Jan. 25, 2021 (GLOBE NEWSWIRE) -- FluroTech Ltd. (TSXV: TEST) (OTCQB: FLURF) (“FluroTech” or the “Company”), is pleased to announce that, FluroTest Ltd. (“FluroTest”) has retained...
FluroTech Announces Closing of Oversubscribed $2.5 Million Private Placement Financing and Announces Communications Engagement for Investor Relations Services
January 21, 2021 14:00 ET
|
FluroTech Ltd.
CALGARY, Alberta, Jan. 21, 2021 (GLOBE NEWSWIRE) -- FluroTech Ltd. (TSXV: TEST) (OTCQB: FLURF) (“FluroTech” or the “Company”), is pleased to announce that it has closed the second and final tranche...
CENTOGENE Expands Partnership with PTC Therapeutics to Generate New Insights for Aromatic L-Amino Acid Decarboxylase (AADC) Deficiency
November 25, 2020 06:30 ET
|
CENTOGENE GmbH
CAMBRIDGE, Mass. and ROSTOCK, Germany and HEIDELBERG, Germany and BERLIN, Nov. 25, 2020 (GLOBE NEWSWIRE) -- Centogene N.V. (Nasdaq: CNTG), a commercial-stage company focused on rare diseases that...
Fujirebio Europe and CENTOGENE Enter Partnership to Provide Rapid and High-Quality Preventive SARS-CoV-2 Antigen Testing
November 09, 2020 04:00 ET
|
CENTOGENE GmbH
GENT, Belgium and CAMBRIDGE, Mass. and ROSTOCK, Germany and BERLIN, Nov. 09, 2020 (GLOBE NEWSWIRE) -- Centogene N.V. (Nasdaq: CNTG), a commercial-stage company focused on rare diseases that...
CENTOGENE Opens Walk-In COVID-19 Testing Facility at Berlin Brandenburg Airport
November 05, 2020 02:00 ET
|
CENTOGENE GmbH
CENTOGENE expands its SARS-CoV-2 testing solution to Berlin Brandenburg Airport (BER) after successfully launching COVID-19 test centers at three major German airports in cooperation with...
Collaboration Between CENTOGENE and U-Diagnostics Increases COVID-19 Testing Capacities in the Netherlands
October 14, 2020 08:14 ET
|
CENTOGENE GmbH
CAMBRIDGE, Mass. and ROSTOCK, Germany and BERLIN and BAARN, the Netherlands, Oct. 14, 2020 (GLOBE NEWSWIRE) -- Centogene N.V. (Nasdaq: CNTG), a commercial-stage company focused on rare diseases...
CENTOGENE Opens Walk-In COVID-19 Testing Facility at Düsseldorf Airport
September 23, 2020 03:30 ET
|
CENTOGENE GmbH
CENTOGENE expands its SARS-CoV-2 testing solution to Düsseldorf Airport after successfully launching walk-in COVID-19 test facilities at Frankfurt and Hamburg AirportCompany’s PCR tests now available...